Announced Tue, 13 Oct, 2026 · 12:36 IST
RTA certificate for share dematerialization filed for Q2FY26
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
Ganga Pharmaceuticals submitted a certificate from its Registrar KFin Technologies under SEBI Regulation 74(5) for the quarter ended September 30, 2026. The RTA confirmed details of shares dematerialized and share certificates cancelled were furnished to BSE, CDSL and NSDL. This is a routine quarterly compliance filing with no business or trading impact.
Likely market impact
Routine regulatory compliance filing. No material impact on shareholders or stock price.